Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,171
Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
for
Acute Pain
Location: Cincinnati OH
Sponsor: Elysium Therapeutics, Inc.
Sex: All
Age: 18 - 55
Code: NCT05572190
Phase1, Recruiting
A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults
for
Healthy
Location: Cincinnati OH
Sponsor: Scholar Rock, Inc.
Sex: All
Age: 18 - 55
Code: NCT07444294
Phase1, Recruiting
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumors
Location: Cincinnati OH, Detroit MI, Pittsburgh PA, Chicago IL,
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Cincinnati OH, Columbus OH, Gahanna OH, Greenwood IN,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
for
Urinary Bladder Neoplasms,
Location: Cincinnati OH, Chicago Ridge IL, Columbia MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06833073
Phase2, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Cincinnati OH, Gahanna OH, Detroit MI, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase3, Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Cincinnati OH, Gahanna OH, Carmel IN, Jeffersonville IN,
Sponsor: Dendreon
Sex: Male
Age: 18+
Code: NCT06134232
Phase2, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Cincinnati OH, Farmington Hills MI, East Lansing MI,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07304089
Phase2, Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Cincinnati OH, Dublin OH, Canton OH, Lansing MI,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06767683
Phase2, Phase3, Recruiting
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
for
Migraine Disorders
Location: Cincinnati OH, Huntington WV, Tampa FL, La Jolla CA,
Sponsor: Upsher-Smith Laboratories
Sex: All
Age: 6 - 11
Code: NCT04748601
Recruiting
The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF
for
Infertility Primary
Location: Cincinnati OH, Nashville TN, Las Vegas NV
Sponsor: Ovation Fertility
Sex: All
Age: 0+
Code: NCT06521372
Recruiting
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
for
Asthma
Location: Cincinnati OH, Cleveland OH, Owensboro KY, Normal IL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 17
Code: NCT05757102
Phase3, Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
for
Growth Hormone Deficiency
Location: Cincinnati OH, Indianapolis IN, Louisville KY,